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1. Introduction  
Bisphosphonates (BPs) are analogues of pyrophosphate in which the oxygen bridge between 
the two phosphates is replaced by a methylene group (–CH2–). Substitution of one or both 
hydrogen atoms of this group by radicals generates a variety of bisphosphonates; usually 
they are grouped into two types, namely non-N-BP and N-BP, depending on the absence or 
presence of a nitrogen atom in its molecule, respectively (Russell, 2011).  Examples of BPs 
used in this report are: etidronate and clodronate (non-N-BPs), and pamidronate and 
alendronate (N-BPs).  
Bisphosphonates are the leading drug class for the treatment of osteoporosis; as an 
indication of their usefulness and the spread out of the disease the combined sales of drugs 
to treat osteoporosis reached $ 6.2 billions in 2004. Besides their application in humans, 
bisphosphonates are also used for other purposes, mainly as herbicides in plants (Cromartie 
et al., 1999; Oberhauser et al., 1998), as chemotherapeutic agents (Artz et al., 2008; Docampo 
& Moreno, 2001; Leon et al., 2006; Moreno & Li, 2008) and in basic research (Rogers et al., 
2010; Russell, 2011).  
The usefulness of bisphosphonates is due to their mechanism of action when they are 
supplied to the living organism. In fact, they have the ability of interfering with metabolic 
pathways located at the crossroads of essential processes for life. Some important examples 
of this crucial role are as follows: 
a) Bisphosphonates may act as analogs of PP in many of the reactions catalyzed by ligases 
and some transferases (reaction 1) in which derivatives of the type NRpp-CH2-p are 
synthesized in the reverse reaction (reaction 2) (Günther Sillero et al., 2008; Günther Sillero 
et al., 2006; Rogers et al., 1996; Russell, 2011).  
 X + NRPPP ----> X-NRP + PP (1) 
 X-NRP + p-CH2-p  ---> NRpp-CH2-p (2) 
 X-NRP + mev-pp --->mevpppN (3) 
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Where X is a potential substrate of the reaction; NRP and NRPPP are nucleosides mono- and 
triphosphates, respectively; NRpp-CH2-p is a nucleoside 5’( methylene triphosphate) and 
mev-pp a compound of the mevalonate pathway with a terminal pyrophosphate (see 
below). As the more abundant nucleoside triphosphate is ATP, the more common derivative 
from bisphosphonate, would be ARpp-CH2-p; given that ATP is a co-substrate of at least 150 
enzymes with transferase activity and more than 90 with ligase activity (see Enzyme 
Nomenclature), bisphosphonates may indirectly interfere with multiple cellular processes 
through the formation of bisphosphonate derivatives of ATP or of any nucleoside 
triphosphate. As in these reactions BPs act as analogs of PP it would be expected that the 
non-N-BP (the smallest type of BP) were the preferred substrates for these reactions. 
b) BPs may be inhibitors of enzymes having substrates with a terminal PP (R-PP) (see below 
and Günther Sillero et al., 2009). Although the inhibition of these enzymes could take place 
at any step of the pathway, specific inhibitions have been reported on isolated enzymes 
from bacteria, yeast or plants: pyrophosphatase (Baykov et al., 1993; Cromartie et al., 1999; 
Drozdowicz et al., 2003; Gordon-Weeks et al., 1999; Kim et al.,1994; Kuo et al., 2005; 
Rodrígues et al., 2000; Szabo & Oldfield, 2001; Zhen et al., 1994 ); geranyl diphospho 
synthetase (Burke et al., 2004; Oberhauser et al., 1998); isopentenyl pyrophosphate synthase 
(Cromartie et al., 1999) and P5C reductase (Forlani et al., 2008). 
c) The synthesis of isopentenyl triphosphoadenosine (iso-pppA) was previously described 
(Monkkonen et al., 2006). Following this finding, the synthesis of derivatives of a variety of 
compounds of the mevalonate pathway capped with an adenosine moiety catalyzed by 
several ligases, was later reported (mev-pppA and mev-ppppA) (Günther Sillero et al., 
2009). Increase in the concentration of metabolites upstream the inhibited step could 
stimulate synthesis of the corresponding mevalonate derivative (reaction 3) (Günther Sillero 
et al., 2009; Rogers et al., 2010). 
Related to the use of bisphosphonates in humans for the treatment of osteoporosis, Paget’s 
disease and bone tumour metastasis it can be stressed that upon their oral or intravenous 
administration BP are partially eliminated by kidney and partially fixed in bones, with very 
little amount in the systemic circulation (Cremers et al., 2005). Being otherwise 
bisphosphonates could have general toxic effects. After their capture by osteoclasts from the 
bone they exert noxious effects on these cells by some of the above-mentioned mechanisms. 
The basic approach, necessary to explore the effect of BPs, is not sufficient to envisage their 
clinical effects. These studies, although mandatory, are cumbersome, costly and requiring a 
cohort of patients as each patient has distinct characteristics and each bisphosphonate may 
present special pharmacokinetic properties (Cremers et al., 2005). 
Based on the above we thought of interest to approach the effect of bisphosphonates in 
plants: plants are a whole living entity, of cheaper handling, where BPs present a quite 
different pharmacokinetics; they are easily assimilated by the roots, are not fixed in a 
structure similar to bones and probably circulate through the vegetal tissues more easily 
than in animal tissues. As an initial approach to the problem, we have used germinating 
seeds and early seedlings of the model plant species Arabidopsis thaliana to investigate the 
alteration of a few phenotypic characters, considered of high relevance for key functions of 
the plant, namely the seed germination rate, the early development of primary and 
secondary roots (essential for establishing the plant developmental pattern) and the 
presence and content of chlorophyll in the first leaves. This later character, used as an 
indicator of the ability of plants for performing the fundamental process of photosynthesis, 
also indicates the alteration of the mevalonate pathway, since chlorophyll is a product of 
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this biosynthetic pathway. We have focused our attention on this pathway as a good target 
to examine the effect of BP given the two metabolic peculiarities present only in the 
mevalonate cycle: occurrence of both three consecutive enzymes requiring ATP as a co-
substrate and the major pool of compounds containing a terminal pyrophosphate in any 
known metabolic pathway (Günther Sillero et al., 2009) (Fig. 1).  
 
 
The metabolic pathway from acetyl-CoA to mevalonate-5-phospahte, and the implicated enzymes (1-5) are 
indicated in the figure. The enzymes are: 1, acetyl-CoA acetyltransferase (EC 2.3.1.9); 2, 
hydroxymethylglutaryl-CoA synthase (EC 4.1.3.5); 3, 3-hydromethylglutaryl-CoA reductase, (EC 1.1.1.34); 4, 
mevalonate kinase (EC 2.7.1.36); 5, phosphomevalonate kinase (EC 2.7.4.2). Note that the three consecutive 
steps catalyzed by enzymes (4), (5) and (A), consume three moles of ATP. The inset in the figure comprises 
the compounds of the mevalonate pathway and the enzymes (A-F) involved: A, diphosphomevalonate 
decarboxylase, (EC 4.1.1.33); B, isopentenyl-diphosphate D-isomerase, (EC 5.3.3.2); C, 
dimethylallyltranstransferase, (EC 2.5.1.1); D, geranyltranstransferase (farnesyl-diphosphate synthase), (EC 
2.5.1.10); E, farnesyltranstransferase, (EC 2.5.1.29); F, farnesyl-diphosphate farnesyltransferase, (EC 2.5.1.21). 
To emphasize the occurrence of pyrophosphate in all the compounds of the cycle, this moiety has been 
marked out (). Some of the great variety of compounds synthesized from those metabolites, and essential 
for plant functions, is annotated. The mevalonate independent pathway is not represented in the Figure.  
Fig. 1. Components of the mevalonate pathway, its precursors and some metabolic 
connections in plants.  
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The cytosol-located mevalonate pathway (starting with 2 moles of acetyl-CoA and ending in 
geranygeranyl pyrophosphate (Fig. 1)) is the starting point for the synthesis of a great 
variety of compounds in bacteria, plants and animals, embracing more than 23,000 currently 
identified compounds (Wendt & Schulz, 1998). A different additional route for the synthesis 
of isopentenyl pyrophosphate is localized in plant plastids. This mevalonate-independent 
pathway starts with the condensation of pyruvate and D-glyceraldehyde 3-phosphate and, 
through the action of seven additional enzyme activities, the synthesis of isopentenyl 
pyrophosphate is obtained (see (Hunter, 2007) for a review).  
This short work is an initial report of this study, showing that the plant growth and 
development, as well as the photosynthetic efficiency, are indeed affected by the presence of 
BPs in the culture medium, in some cases in such an extent that the actual viability of the 
plant is compromised. Apart from its basic interest, this finding could be of some help to 
understand the role of bisphosphonates in animal tissues. 
2. Materials and methods 
The following bisphosphonates were used in this study: alendronate, pC(OH)((CH2)3-NH2)p 
(Ref. A-4978) and etidronate, pC(OH)(CH3)p (Ref. P-5248) were from Sigma; clodronate, 
pCCl2p (Ref. 233183), and pamidronate, pC(OH)((CH2)2-NH2)p, (Ref. 506600) were from 
Calbiochem. In addition, sodium pyrophosphate and tripolyphosphate (P3), used in 
controls, were from Sigma (Refs P9146 and T-5633, respectively). 
Seeds of Arabidopsis thaliana ecotype Columbia were placed in Petri dishes containing 
Murashige and Skoog’s (MS) medium (Duchefa) in agar supplemented with one of the four 
bisphosphonates (BPs) indicated, at a concentration of 0.05 mM, 0.1 mM or 0.5 mM. Controls 
consisted of culture medium alone, or supplemented with pyrophosphate (0.1 mM or 0.5 
mM), or tripolyphosphate (0.1 mM or 0.5 mM). Plates were placed vertically and incubated 
at 22ºC under illumination with a flux of photo synthetically active photons of 150-µE m-2 s-1, 
with a photoperiod of 16 hours of light and 8 hours of darkness. Samples were 
photographed at 4, 8 and 11 days of incubation and analyzed for the following parameters: 
a) rate of germination; b) length of the primary root; c) time of appearance, number and 
length of secondary roots; and d) colour of leaves. 
3. Results and discussion 
The plants were analyzed by the rate of seed germination and, in germinated seedlings, by 
the occurrence and aspect of three visible phenotypic characters: growth (length) of the 
primary root, development of secondary roots (time of appearance, position, number and 
length) and colour of the leaves, indicative of the presence of chlorophyll. The full set of 
results obtained for every evaluated parameter with the four BPs, at the three concentrations 
and in the three time points of sampling assayed, is shown in Table 1. 
In order to facilitate the presentation of the results, the experimental conditions have been 
numbered from 1-12 (#column at the right in Table 1). Furthermore, representative results 
corresponding to A. thaliana seedlings grown during 4, 8 and 11 days in the presence of 0.1 
mM etidronate; 0.05 mM clodronate; 0.5 mM pamidronate and 0.5 mM alendronate are 
shown in Fig. 2. Controls grown without any addition to the culture medium (a-c), or in the 
absence of BPs, but in the presence of pyrophosphate (d-f) or tripolyphosphate (g-i), were 
also included in Fig. 2. 
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The expressed results are referred to the control experiment performed with standard culture medium, 
without the addition of any other substance. Number of (+) indicates deviation with respect to the 
control experiment for the particular parameter evaluated. (): Similar to the control experiment. na: 
Not applicable, because secondary roots were not initiated in the corresponding control samples. #: 
Reference number of the experiment, attributed for the sake of clarity in the description and discussion 
of results. 
Table 1. Summary of results obtained on Arabidopsis thaliana seedlings with the four 
bisphosphonates analyzed, the three parameters evaluated and the nine conditions used, 
resulting from the combination of three concentrations and three times of incubation for 
each bisphosphonate.  
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In this initial approach, the estimation of the effects of BPs on the characters investigated has 
been performed in a semi-quantitative way, by recording the differences that can be 
appreciated in these parameters by a simple visual inspection. The purpose of this type of 
analysis was, firstly, to determine whether or not BPs are potent inhibitors of essential 
functions of the plant; secondly, to discriminate differential effects between the analyzed 
BPs, the concentrations used and the times of development, in order to select targets for a 
more detailed and deep mechanistic analysis that may provide relevant information on the 
specific biochemical reactions that become affected during the inhibitory process. 
From the full set of data presented in Table 1, and the selected images shown in Fig. 2, the 
most relevant results of our study are as follows:  
a) None of the tested BPs, at any of the concentrations assayed, affected the seed 
germination rate. b) Clodronate, pamidronate and alendronate affected both the growth of 
the primary root, resulting in its shortening, and the number and length of secondary roots 
(Table 1 and Fig. 2, m-o; p-r; s-u). c) Two BPs, belonging to the same group of non-N-BP 
(etidronate and clodronate) showed effects of quite different intensity on root development, 
and might have a different degree of action (Fig. 2, j-l; m-o) (Table 1, compare 1-3 and 4-6). 
d) The effect of BPs is time dependent, and the highest effect was obtained after 11 days in 
culture, irrespective of the concentration used. In few cases we observed that the maximum 
effect was already reached after 8 days and then it persisted after longer time in culture (Fig. 
2, n-o; t-u) (Table 1, line 4, 0.05 mM; line 7, 0.5 mM; line 10, 0.5 mM). e) The effect of BPs 
regarding the alteration of primary root growth was concentration dependent. This feature 
was more clearly observed with N-BPs rather than with non-N-BPs. However, in the 
particular case of etidronate, concentrations of 0.05 mM seemed to be more effective than 0.1 
mM (Table 1, line 1), a striking result of difficult interpretation. f) There are visible 
differences on the influence of BPs on chlorophyll loss: non-N-BPs either did not affect 
visibly that parameter, even at 0.5 mM and during 11 days in culture (etidronate; Table 1, 
line 3), or affected only slightly at the highest concentration (clodronate; Table 1, line 6); on 
the contrary, N-BPs, such as alendronate (Table 1, line 12) and to a lesser extent 
pamidronate, greatly affected the colour of the leaves (Table 1, line 9) (Fig. 2, p-r; s-u). In 
general, conspicuous effect on chlorophyll loss was only detected at the highest BP 
concentrations. g) Alendronate was the most effective BP acting on Arabidopsis thaliana 
development, affecting the primary and secondary roots and chlorophyll loss, producing a 
drastic inhibition of seedling growth, with total loss of chlorophyll, which was observed at a 
concentration of 0.5 mM, already in the intermediate time point of sampling (Fig. 2, t-u) 
(Table 1, lines 10, 11 and 12). 
Images from a to i correspond to controls, either with the standard MS culture medium 
alone (a to c), or with the addition of pyrophosphate (d to f), or with the addition of 
tripolyphosphate (g to i): the analysis of the features of these control samples (a to i) does 
not reveal significant differences among them. From j to l: culture in the presence of 0.1 mM 
etidronate for 4, 8 and 11 days, respectively; images j and k are practically unaltered with 
respect to controls; root length similar to controls, but secondary roots are much less 
developed (l). From m to o: culture in the presence of 0.05 mM clodronate for 4, 8 and 11 
days, respectively; at the 4th day of growth, primary roots are shorter (m) than the controls 
(a, d and g) and the root growth appears practically arrested in successive samples (n to o); 
secondary roots are totally absent (o). From p to r: culture in the presence of 0.5 mM 
www.intechopen.com
Effect of Bisphosphonates on Root Growth  
and on Chlorophyll Formation in Arabidopsis thaliana Seedling 
 
859 
 
Fig. 2. Selected images of the results obtained after the germination and growth of 
Arabidopsis thaliana seedlings in the presence of four different bisphosphonates.  
pamidronate for 4, 8 and 11 days, respectively; at the 4th day of growth, primary roots are 
shorter (p) than the controls (a, d, g); the root growth does not progress further (q to r); 
leaves show a pale yellowish colour in all cases, but this effect is more intense as the culture 
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in the presence of the drug progresses in time. From s to u: culture in the presence of 0.5 mM 
alendronate for 4, 8 and 11 days, respectively; the root growth is severely hampered in these 
conditions; 8 - and 11-day old seedlings show an almost white colour of leaves, indicative of 
a very serious loss of chlorophyll. 
The above results can be interpreted as a consequence of the toxic effects of BPs on the 
mevalonate pathway of Arabidopsis thaliana (Fig. 1). Isoprenoids, the most diverse group of 
natural products, are synthesized in prokaryotes and eukaryotes, animals and plants by 
condensation of isopentenyl pyrophosphate and dimethylallyl pyrophosphate. They play 
important and diverse roles in the synthesis of quinones, sterols, prenylation of proteins, 
photosynthetic pigments, hormones, attractants for pollinators in plants, and others. 
Certainly, most of the studies on the synthesis of isoprenoids were carried out in animal 
tissues; however, after the more recent discovery of the synthesis of isoprenoids by the 
mevalonate independent pathway operating in plants, new approaches on their metabolism 
and function have been undertaken in other biological model systems (Eisenreich et al., 
2004; Lange et al., 2000; Rodriguez-Concepcion & Boronat, 2002; Rohmer, 1999). The plastid 
mevalonate independent pathway involves the synthesis of 1-deoxy-D.xilulose from 
pyruvate and glyceraldehydes-3-phosphate. There is a cross talk between the cytosolic and 
plastidial pathway for the synthesis of isoprenoids in Arabidopsis thaliana (Laule et al., 2003). 
In relation with the postulated inhibitory role of bisphosphonates on the synthesis of 
isoprenoids, it could be noted that the two last compounds in that synthesis by the 
mevalonate independent pathway (2-C-methyl-D-erythritol 2, 4, cyclo pyrophosphate and 
hydroxymethybutenyl-4 pyrophosphate) both contain a terminal pyrophosphate; in 
addition, isopentenyl and dimethylallyl pyrophosphate, common to the two pathways, also 
contain a terminal pyrophosphate (Fig. 1). All these points could be raised in favour of the 
inhibitory effects of bisphosphonates on the synthesis of isoprenoids and hence on the 
development of Arabidopsis thaliana. 
The mevalonate pathway is responsible, in plants, of the production of different 
phytohormones, among which cytokinins (Letham & Palni, 1983). Cytokinins have been 
shown to reverse the effects of lovastatin, an inhibitor of 3-hydroxy-3-methylglutaryl 
coenzyme A reductase, the enzyme catalyzing the synthesis of mevalonate (Crowell & Salaz 
1992). Although root growth and lateral growth formation are preferentially determined by 
auxins, a role of cytokinins in root development has been described, coherent with their role 
in promoting cell division, specifically in root meristematic cells. Cytokinins, synthesized in 
the root cap, promote cytokinesis, vascular differentiation, root apical dominance and 
gravitropism (Aloni et al., 2006). Therefore, the observed effects of BPs on root growth and 
development may, in principle, be attributed to an inhibitory effect of BPs on cytokinins, 
although an indirect effect on the synthesis and/or transport of auxins cannot be excluded 
either. Whereas the differential effect of the various assayed BPs on root growth and 
development is unequivocal, additional work is necessary to understand the reasons for this 
differential effect and the mechanisms of the inhibition throughout the action of one or more 
phytohormones. 
Finally, the importance of the mevalonate pathway in the biological systems can also be 
contemplated from an evolutionary viewpoint: isoprenoids are the oldest known 
biomolecules recovered from sediments, as old as 2.5 billion years (Summons et al., 2006); 
the mevalonate pathway is germane to archaebacteria (Lange et al., 2000) and finally, 
farnesyl diphosphate synthase and polypropenyl synthase activities have been reported as 
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present in the hypothetical Last Universal Common Ancestor (LUCA) (Ranea et al., 2006). 
All the above points could be also considered as examples of the multiple relationships 
interconnecting all the biological cycles on earth. 
4. Conclusions  
Bisphosphonates are widely used in the treatment of osteoporosis and hence their great 
importance in clinical investigation. Upon their administration they bind to the bone tissues 
where they exert a noxious effect mainly on the mevalonate pathway of the osteoclasts. 
Given the universality of this pathway, present in bacteria, plants and animals, it seemed to 
us of interest to analyze the effect of etidronate, clodronate (non containing nitrogen or non-
N-BPs), pamidronate and alendronate (N-BPs) on some visible traits of the model plant 
Arabidopsis thaliana. The seeds were grown in a medium containing three concentrations 
(0.05 mM, 0.1 mM or 0.5 mM) of each bisphosphonate and the growth of primary and 
secondary roots and formation of chlorophyll were observed during early development of 
the seedlings. Each bisphosphonate showed a different pattern of influence on those 
parameters. In general, the inhibitory effects were, in increasing order: etidronate, 
pamidronate, clodronate, and alendronate. Specific effects on the evaluated parameters 
ranged from simple reduction in the number and length of secondary roots caused by 0.1 
mM etidronate, only after 11 days of culture, until a drastic inhibition of seedling growth, 
with total loss of chlorophyll observed with 0.5 mM alendronate already in the intermediate 
time point of sampling. The utility of the use of plants to analyze the action of 
bisphosphonates is suggested. 
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